Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model

Journal of Autoimmunity

Volumn 37, Issue 3, 2011, Pages 242-253

  Hintermann, Edith ^a   Holdener, Martin ^a   Bayer, Monika ^a   Loges, Stephanie ^b   Pfeilschifter, Josef M ^a   Granier, Claude ^c   Manns, Michael P ^b   Christen, Urs ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CNRS   (France)

Author keywords

Immunodominance; Molecular mimicry; Pathogen infection

Indexed keywords

ADENOVIRUS VECTOR; CYTOCHROME P450 2D6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE HEPATITIS; DISEASE COURSE; DNA DETERMINATION; EPITOPE MAPPING; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ADENOVIRIDAE; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CHILD; CYTOCHROME P-450 CYP2D6; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNODOMINANT EPITOPES; MICE; MICE, TRANSGENIC; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA;

EID: 80855148161     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.06.005     Document Type: Article

References (46)

1. Czaja A.J., Manns M.P. Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis. Gastroenterology 2010.
2. Manns M.P., Czaja A.J., Gorham J.D., Krawitt E.L., Mieli-Vergani G., Vergani D., et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010, 51:2193-2213.
3. Oldstone M.B.A. Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbiol Immunol 1989, 145:127-136.
4. Christen U., von Herrath M.G. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 2004, 40:1113-1120.
5. Holdener M., Hintermann E., Bayer M., Rhode A., Rodrigo E., Hintereder G., et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008, 205:1409-1422.
6. Gueguen M., Boniface O., Bernard O., Clerc F., Cartwright T., Alvarez F. Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody. J Autoimmun 1991, 4:607-615.
7. Kitazawa E., Igarashi T., Kawaguchi N., Matsushima H., Kawashima Y., Hankins R.W., et al. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients. J Autoimmun 2001, 17:243-249.
8. Manns M.P., Griffin K.J., Sullivan K.F., Johnson E.F. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991, 88:1370-1378.
9. Yamamoto A.M., Cresteil D., Boniface O., Clerc F.F., Alvarez F. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur J Immunol 1993, 23:1105-1111.
10. Klein R., Zanger U.M., Berg T., Hopf U., Berg P.A. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol 1999, 118:290-297.
11. Kerkar N., Choudhuri K., Ma Y., Mahmoud A., Bogdanos D.P., Muratori/ L., et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003, 170:1481-1489.
12. Imaoka S., Obata N., Hiroi T., Osada-Oka M., Hara R., Nishiguchi S., et al. A new epitope of CYP2D6 recognized by liver kidney microsomal autoantibody from japanese patients with autoimmune hepatitis. Biol Pharm Bull 2005, 28:2240-2243.
13. Sugimura T., Obermayer-Straub P., Kayser A., Braun S., Loges S., Alex B., et al. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens. Autoimmunity 2002, 35:501-513.
14. Zachou K., Rigopoulou E., Dalekos G.N. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 2004, 1:2.
15. Lunel F., Abuaf N., Frangeul L., Grippon P., Perrin M., Le Coz Y., et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992, 16:630-636.
16. Michel G., Ritter A., Gerken G., Meyer zum Buschenfelde K.H., Decker R., Manns M.P. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992, 339:267-269.
17. Lenzi M., Ballardini G., Fusconi M., Cassani F., Selleri L., Volta U., et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990, 335:258-259.
18. Miyakawa H., Kitazawa E., Kikuchi K., Fujikawa H., Kawaguchi N., Abe K., et al. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C. Autoimmunity 2001, 33:23-32.
19. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157.
20. Christen U., Thuerkauf R., Stevens R., Lesslauer W. Immune response to a recombinant human TNFR55-IgG1 fusion protein: auto-antibodies in rheumatoid arthritis (RA) and multiple sclerosis (MS) patients have neither neutralizing nor agonist activities. Hum Immunol 1999, 60:774-790.
21. Corchero J., Granvil C.P., Akiyama T.E., Hayhurst G.P., Pimprale S., Feigenbaum L., et al. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse. Mol Pharmacol 2001, 60:1260-1267.
22. Manns M., Gerken G., Kyriatsoulis A., Staritz M., Meyer zum Buschenfelde K.H. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987, 1:292-294.
23. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996, 70:4805-4810.
24. Parez N., Herzog D., Jacqz-Aigrain E., Homberg J.C., Alvarez F. Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients. Clin Exp Immunol 1996, 106:336-343.
25. Gueguen M., Yamamoto A.M., Bernard O., Alvarez F. Anti-liver-kidney microsome antibody type 1 recognizes human cytochrome P450 db1. Biochem Biophys Res Commun 1989, 159:542-547.
26. Manns M.P., Johnson E.F., Griffin K.J., Tan E.M., Sullivan K.F. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989, 83:1066-1072.
27. Oldstone M.B.A. Molecular mimicry and autoimmune disease. Cell 1987, 50:819-820.
28. Christen U., Hintermann E., Holdener M., von Herrath M.G. Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?. J Autoimmun 2010, 34:38-44.
29. Rose N.R., Mackay I.R. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000, 57:542-551.
30. von Herrath M.G., Fujinami R.S., Whitton J.L. Microorganisms and autoimmunity: making the barren field fertile. Nat Rev Microbiol 2003, 1:151-157.
31. Mamula M.J., Lin R.H., Janeway C.A., Hardin J.A. Breaking T cell tolerance with foreign and self co-immunogens. a study of autoimmune B and T cell epitopes of cytochrome c. J Immunol 1992, 149:789-795.
32. Strassburg C.P., Vogel A., Manns M.P. Autoimmunity and hepatitis C. Autoimmun Rev 2003, 2:322-331.
33. Ferri S., Muratori L., Lenzi M., Granito A., Bianchi F.B., Vergani D. HCV and autoimmunity. Curr Pharm Des 2008, 14:1678-1685.
34. Marceau G., Lapierre P., Beland K., Soudeyns H., Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?. Hepatology 2005, 42:675-682.
35. Van Regenmortel M.H. Structural and functional approaches to the study of protein antigenicity. Immunol Today 1989, 10:266-272.
36. Rowland P., Blaney F.E., Smyth M.G., Jones J.J., Leydon V.R., Oxbrow A.K., et al. Crystal structure of human cytochrome P450 2D6. J Biol Chem 2006, 281:7614-7622.
37. Homepage TEDDY study: http://teddy.epi.usf.edu/.
38. Christen U., Herrath M.G. Initiation of autoimmunity. Curr Opin Immunol 2004, 16:759-767.
39. Christen U., von Herrath M.G. Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?. Cell Mol Immunol 2011, 8:183-188.
40. Christen U., Edelmann K.H., McGavern D.B., Wolfe T., Coon B., Teague M.K., et al. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 2004, 114:1290-1298.
41. Croxford J.L., Anger H.A., Miller S.D. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J Immunol 2005, 174:907-917.
42. Sutti S., Vidali M., Mombello C., Sartori M., Ingelman-Sundberg M., Albano E. Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry. J Hepatol 2010, 53:431-438.
43. Eliasson E., Kenna J.G. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 1996, 50:573-582.
44. Vidali M., Stewart S.F., Rolla R., Daly A.K., Chen Y., Mottaran E., et al. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 2003, 37:410-419.
45. Ma Y., Bogdanos D.P., Hussain M.J., Underhill J., Bansal S., Longhi M.S., et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006, 130:868-882.
46. Longhi M.S., Hussain M.J., Bogdanos D.P., Quaglia A., Mieli-Vergani G., Ma Y., et al. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 2007, 46:472-484.